It appears the FDA aren't convinced it works. The only published RCT says it doesn't. I think I see the problem.
' Remestemcel-L did not meet the primary endpoint of greater DCR in the intent-to-treat population (35% versus 30%; P = 0.42).'
Whats all the whining about?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.030(1.80%) |
Mkt cap ! $2.153B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.74 | $1.67 | $6.647M | 3.897M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 44280 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 50150 | 5 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |